Posted on February 9, 2011 by Albin Paul
AstraZeneca Pharmaceuticals LP (NYSE: AZN) and HealthCore, Inc., the health outcomes research subsidiary of WellPoint, Inc. (NYSE: WLP), announced a collaborative agreement to conduct real-world studies designed to determine how to most effectively and economically treat disease Unlike controlled clinical trials, real-world evidence studies use observational data such as electronic medical records, claims information and [...]
Filed under: clinical research, Clinical Trial, personalized medicine, Pharmacogenomics | Leave a Comment »
Posted on February 3, 2011 by Albin Paul
Posted on November 17, 2010 by Albin Paul
According to a new report from the Tufts Center for the Study of Drug Development at Tufts University 12 to 50 percent of the drugs companies are developing, depending on the company, involved a personalized medicine approach. The Tufts report is based on a survey of 25 companies, large and small, to which 16 companies [...]
Filed under: clinical research, Clinical Trial, drug development, drug discoverry, personalized medicine, Pharmacogenomics, Theranostics | Tagged: Drug Development, drug discovery, personalized medicine, theranostics | Leave a Comment »
Posted on September 30, 2010 by Albin Paul
The Institute is focused on research that will accelerate IT innovation to advance personalized medicine and the delivery of safe and effective treatments and health care services to patients around the globe. OHSI will work in tandem with academic research centers, focusing on a targeted set of research areas fundamental to the R&D and [...]
Filed under: Drug Safety, genetic medicine, Online Data sharing, open access database, open source, oracle, Oracle Health Sciences Global Business Unit, Patient Safety, personalized medicine, Pharmacogenomics, pharmacovigilance | Tagged: Drug Safety, health sciences global business unit, HSGBU, OHSI, Open Source Drug Development Network, oracle, Oracle Health Science Global Business Unit, Oracle Health Sciences Institute, personalized medicine, Pharmacogenomics, pharmacovigilance, Sun Labs | 1 Comment »
Posted on December 18, 2007 by Albin Paul
CombiMatrix has completed the clinical validation of the BAC array CGH based clinical microarray tests. ATScan is designed to detect known genomic copy-number variations associated with Autism Spectrum Disorder and this test is now available to physicians and consumers.
Filed under: Clinical microarrays, microarray blog, microarray for clinical diagnostics, Next Generation of DNA and RNA Microarrays, personalized medicine, Pharmacogenomics | 3 Comments »
Posted on November 1, 2007 by Albin Paul
Which of the thousands of long stretches of repeated DNA in the human genome came first? And which are the duplicates the question have been answered by a team of scientists from University of Washington School of Medicine and University of California, San Diego.The research published by Evan Eichler from the University of Washington School [...]
Filed under: bioinformatics, bioinformatics blog, DNA, DNA news, evolution, genetics, genome sequencing, Pharmacogenomics | Leave a Comment »
Posted on October 15, 2007 by Albin Paul
It hardly a week I have wrote about acquisition and mergers , it seems the rain is noit going to stop any time soon, the latest one , to give away the home plate is Genelogic agreeing to sell its genomics division to India HQ Ocimum Biosolutions subject to the authorization of the transaction at [...]
Filed under: bioinformatics blog, bioinformatics company, bioinformatics industry, Genomics, genomics company, microarray blog, microarray business, outsourcing, personalized medicine, Pharmacogenomics, toxicogenomics | Leave a Comment »
Posted on October 11, 2007 by Albin Paul
Its the time -Personalized Genomics Advances in genetic information and laboratory technologies mean new ways to diagnose disease and determine patient risk. The wealth of genetic information makes it harder to provide meaningful information. During Oracle OpenWorld 2007 Oracle is presenting how laboratory information systems principles and Oracle customer relationship management and enterprise resource planning [...]
Filed under: bioinformatics, clinical genomics, microarray blog, oracle, personalized medicine, Pharmacogenomics | Leave a Comment »
Posted on August 30, 2007 by Albin Paul
Scientists from the Lucile Packard Children’s Hospital and the Stanford University School of Medicine have identified a pattern of gene expression shared by a small group of patients who beat the odds and remained healthy for years without medication, after undergoing Organ transplant. The findings made by Minnie Sarwal, MD, PhD, a pediatric nephrologist at [...]
Filed under: biodefense, bioinformatics blog, cancer, clinical genomics, DNA, DNA diagnostics, gene expression, gene therapy, genetic medicine, genetics, Genomics, microaray blog, Pharmacogenomics, transgenomics | 9 Comments »
Posted on August 23, 2007 by Albin Paul
THe Haifa Lab of IBM provides the Technlogy for Clinicalgenomics and leads the research in lifesciences fieds. The Clinica, Genomics division plans to provide technology to integrate clinial genomics data and HL7 and other complaince protocls followed in clinical research and clinia, trial and integrate them to provide better and focused clinical trials Clinical genomics [...]
Filed under: bioinformatics, clinical genomics, clinical microarray, DNA, DNA diagnostics, gene expression, gene therapy, genetics, microarray blog, Pharmacogenomics, Theranostics | Leave a Comment »
Posted on August 20, 2007 by Albin Paul
IT been a long time since my last post, So I thought of catching up with other blogger before going to do anything myslef. So here is what got my attention from Alla Katsnelson blog on the scientist magazine that USFDA approved updated labeling for the widely used blood-thinning drug, Coumadin, to explain that people’s [...]
Filed under: gene expression, genetics, Genomics, microarray blog, personalized medicine, Pharmacogenomics, science blog | 1 Comment »
Posted on July 21, 2007 by Albin Paul
Affymetrix expands into personalized medicine! Why because The next big thing in health care? is You the individual personalized medicine is the place step every one wants to be. Roche recently went after Nimblegen for a small foothold in this developing ssicne field, Now its the turn of Affymetrix the leader in microarray DNA chips. [...]
Filed under: Affymetrix, bioinformatics blog, DNA medicine, gene expression, genetics, Genomics, microarray blog, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics, Theranostics | 2 Comments »
Posted on July 5, 2007 by Albin Paul
The average human gene consists of 3000 bases, but sizes vary greatly, with the largest known human gene being dystrophin at 2.4 million bases. Residing at Chromosome 4 it has long been of interest to the medical community because its the gene responsible for huntington’s disease, polycystic kidney disease, a form of muscular dystrophy and [...]
Filed under: clinical diagnostics, clinical microarray, DNA diagnostics, gene expression, genetic medicine, genetic testing, microarray blog, microarray for clinical diagnostics, Pharmacogenomics | 7 Comments »
Posted on June 7, 2007 by Albin Paul
Imagine a diabetic patient from NewYork being put on a drug regimen distinct from a patient London. Personalized medicine allows tratement to decided on the genetic make up of the individual. Genetically europeans and asians and others have different ways of responding to same treatment genetically FortunatelyIf Indian researchers have their way, such customised medication [...]
Filed under: clinical diagnostics, DNA database, DNA diagnostics, DNA therapeutics, gene expression, gene therapy, genetic medicine, genetics, genotyping, microarray blog, personalized medicine, Pharmacogenomics | 6 Comments »
Posted on June 6, 2007 by Albin Paul
UK is appealing for volunteers to help worlds biggest medical experiment project- to understand impact of Genetics and lifestyle in health and medical treatment The BBC reports about a medical experiment aiming to be the biggest in the world is appealing for volunteers to help end Scotland’s reputation as the “sick man of Europe”. The [...]
Filed under: clinical diagnostics, DNA database, DNA medicine, DNA network, funding for Genetics, gene expression, genetic medicine, genetics, Genomics, genotyping, microarray, personalized medicine, Pharmacogenomics | 4 Comments »
Posted on June 5, 2007 by Albin Paul
The complete list is published at forbes website Breast Cancer Adult-Onset Diabetes Obesity Drug Metabolism Crohn’s Disease Prostate Cancer Duchenne Muscular Dystrophy Rett Syndrome Macular Degeneration Alzheimer’s Disease Heart Attack Gene Testing: Related Blogs eyeondna , gensherpa , OmicsOmics
Filed under: clinical diagnostics, diagnostic microarray, DNA diagnostics, DNA medicine, DNA therapeutics, gene expression, genetics, Genomics, microarray, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics | 1 Comment »
Posted on June 2, 2007 by Albin Paul
During 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle a new methid for Regulating Expression of therapeutic Genes was introduced. For many applications, gene transfer is being employed to engineer cells for therapeutic applications, chek the following links for article 1 IFR , 2 (Nature), 3 (NIH) , that require [...]
Filed under: bioinformatics blog, DNA, DNA medicine, DNA network, DNA news, DNA therapeutics, gene expression, gene therapy, genetic medicine, genetics, personalized medicine, Pharmacogenomics, transgenomics | 1 Comment »
Posted on May 22, 2007 by Albin Paul
Geneticists have identified a link between the number of copies of a specific gene an individual has and their susceptibility to autoimmune diseases like lupus. The research by Professor Tim Aitman of the Medical Research Council Clinical Sciences Centre at Imperial College London, and colleagues, is published in Nature Genetics. From Medical News
Filed under: gene expression, genetics, genome sequencing, Genomics, genotyping, microarray, personalized medicine, Pharmacogenomics, Theranostics | 19 Comments »
Posted on May 21, 2007 by Albin Paul
Prof. David Dandy of Colorado State University chemical and biological engineering has proven that called microarray assays can be used for biomedical disease and drug screening assays could rapidly increase drug discovery, Although not ready for hospital or office use, microarrays represent a novel miniaturized multi-spot diagnostic format that has huge potential for patient diagnosis [...]
Filed under: clinical diagnostics, clinical microarray, Clinical microarrays, custom microarray, diagnostic microarray, DNA microarray, gene expression, Genomics, microarray, microarray blog, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics, Theranostics | Leave a Comment »
Posted on April 26, 2007 by Albin Paul
Oregon Health & Science University effort, launched 25-April 2007 during National DNA Day, will meld genetics and clinical care OHSU today is launching the Human Genetics Initiative (HGI), an effort that brings together the university’s vast array of genetics research resources and brainpower, and applies them in a health care setting. It will allow the [...]
Filed under: bioinformatics blog, clinical microarray, epigenetics, gene expression, genetics, genotyping, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics, Theranostics | 7 Comments »